{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:17:55Z","timestamp":1771467475570,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["ISR-ES-18-10514"],"award-info":[{"award-number":["ISR-ES-18-10514"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20CIII\/00004"],"award-info":[{"award-number":["PI20CIII\/00004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16CIII\/0002\/0002"],"award-info":[{"award-number":["RD16CIII\/0002\/0002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection remains a substantial health problem as a leading cause of chronic liver disease worldwide [...]<\/jats:p>","DOI":"10.3390\/jcm10040611","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T14:04:13Z","timestamp":1612706653000},"page":"611","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Challenging Road to Hepatitis C Virus Eradication"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-9264","authenticated-orcid":false,"given":"Isidoro","family":"Mart\u00ednez","sequence":"first","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, 28220 Majadahonda, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-7419","authenticated-orcid":false,"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[{"name":"Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-2422","authenticated-orcid":false,"given":"Jorge","family":"Valencia","sequence":"additional","affiliation":[{"name":"Hospital Universitario Infanta Leonor, 28031 Madrid, Spain"},{"name":"Unidad de Reducci\u00f3n de Da\u00f1os \u201cSMASD\u201d, 28004 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0450","authenticated-orcid":false,"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[{"name":"Unidad de Infecci\u00f3n Viral e Inmunidad, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, 28220 Majadahonda, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"ref_1","unstructured":"The Polaris Observatory HCV Collaborators (2017). Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol., 2, 161\u2013176."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cid\/ciw869","article-title":"Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration","volume":"64","author":"Morris","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","first-page":"20","article-title":"Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugpo.2019.06.016","article-title":"High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units","volume":"72","author":"Valencia","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugpo.2017.08.001","article-title":"Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy","volume":"47","author":"Grebely","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14787210.2019.1604221","article-title":"Strategies for the improvement of HCV testing and diagnosis","volume":"17","author":"Chevaliez","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_8","unstructured":"World Health Organization (2016). Global health sector strategies. Viral hepatitis, 2016\u20132021, World Health Organization."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13011-020-00306-1","article-title":"Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: A systematic review and Meta-analysis","volume":"15","author":"Karimi","year":"2020","journal-title":"Subst Abus. Treat. Prev. Policy"},{"key":"ref_10","first-page":"67","article-title":"Micro-elimination of hepatitis C virus","volume":"40","author":"Hollande","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cgh.2018.08.080","article-title":"Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens","volume":"17","author":"Eckman","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination\u2014A path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/joim.12972","article-title":"We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade","volume":"286","author":"Lazarus","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Valerio, H., Alavi, M., Silk, D., Treloar, C., Martinello, M., Milat, A., Dunlop, A., Holden, J., Henderson, C., and Amin, J. (2020). Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa571"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14737159.2017.1400385","article-title":"Hepatitis C point-of-care diagnostics: In search of a single visit diagnosis","volume":"17","author":"Grebely","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/s41598-019-41139-8","article-title":"Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysis","volume":"9","author":"Bellon","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.idc.2018.02.010","article-title":"Hepatitis C Virus Diagnosis and the Holy Grail","volume":"32","author":"Applegate","year":"2018","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","article-title":"Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia","volume":"61","author":"Bajis","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40265-017-0753-x","article-title":"Resistance Mechanisms in Hepatitis C Virus: Implications for Direct-Acting Antiviral Use","volume":"77","author":"Bagaglio","year":"2017","journal-title":"Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.02.018","article-title":"Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy","volume":"71","author":"Macias","year":"2019","journal-title":"J. Hepatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/611\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:20:14Z","timestamp":1760160014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040611"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040611","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]}}}